Longitudinal Goal Attainment With Repeat Injections of AbobotulinumtoxinA in Adults With Lower Limb Spasticity: Results From a Prospective Observational Study
Archives of Physical Medicine and Rehabilitation · 2025
DOI: 10.1016/j.apmr.2024.10.017 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Archives of Physical Medicine and Rehabilitation, 2025. Verfasst von Alberto Esquenazi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of PM&R, MossRehab Jefferson Health, Elkins Park, PA. Electronic address: Alberto.Esquenazi@jefferson.edu. Hauptthemen laut MEDLINE: Botulinum Toxins, Type A, Muscle Spasticity, Lower Extremity, Neuromuscular Agents. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ipsen Biopharmaceuticals, Ipsen Pharma SAS.
Abstract (Originalsprache)
OBJECTIVE: To assess longitudinal goal attainment with repeat abobotulinumtoxinA (AboBoNT-A) injections for lower limb spasticity (LLS) over 16 months. DESIGN: Prospective, longitudinal, international, multicenter, observational study (NCT04050527). SETTING: Specialist neurorehabilitation centers. PARTICIPANTS: Ambulatory adults with unilateral LLS able to take ≥5 steps with/without assistance (effectiveness population, N=384). INTERVENTIONS: Participants received ≥1 AboBoNT-A treatment cycle administered in accordance with local prescribing guidelines to achieve individualized treatment goals. MAIN OUTCOME MEASURES: The primary endpoint was goal attainment as assessed using the cumulated Goal Attainment Scaling-Leg (GAS-leg) T score, across all treatment cycles for each patient. RESULTS: Overall, participants underwent a median of 5 lower limb injection cycles (median dose 600U, range 100-1475U) with a mean±SD injection interval of 18.3±6.1 weeks. Participants generally achieved their goals as expected over repeated cycles; the mean (95% CI) GAS-leg T score at cycle 1 baseline was 38.0 (37.7, 38.3) and the mean cumulated GAS-leg T score at 16 months was 48.2 (47.4, 48.9) (mean change from a baseline of 9.9 [9.1, 10.7]). Participants injected with a guidance technique at baseline were more likely to attain their cycle 1 primary treatment goals (odds ratio: 1.9 [95% CI 1.1, 3.1], P=.02). Overall, 56 (13.5%) participants reported ≥1 adverse event, of which 6 participants (1.4%) had a treatment-related adverse event. CONCLUSIONS: Findings from this large, international study provide evidence for the benefit of repeated cycles of AboBoNT-A for LLS. Multivariate analyses indicated that goal attainment during the first cycle was better with those injected using injection guidance than those injected without guidance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of PM&R, MossRehab Jefferson Health, Elkins Park, PA. Electronic address: Alberto.Esquenazi@jefferson.edu.
- Department of PM&R, MedStar Health, Washington and Georgetown University School of Medicine, Washington, DC.
- Department of PM&R, London North West University Healthcare NHS Trust, Regional Hyper-acute Rehabilitation Unit, Northwick Park Hospital, London, UK.
- Department of PM&R, Ipsen, Boulogne-Billancourt, France.
- Department of PM&R, Ipsen, Munich, Germany.
- Department of PM&R, Centro de Medicina de Reabilitaçãode Alcoitão, Serviço de Reabilitação de adultos 3, Estoril, Portugal.
Förderung
- Ipsen Biopharmaceuticals
- Ipsen Pharma SAS
Zitieren
APA
Esquenazi, A., Zorowitz, R. D., Ashford, S., Beneteau, M., Maisonobe, P., Hannes, C., Jacinto, J., & AboLiSh Study Group (2025). Longitudinal Goal Attainment With Repeat Injections of AbobotulinumtoxinA in Adults With Lower Limb Spasticity: Results From a Prospective Observational Study. Archives of Physical Medicine and Rehabilitation. https://doi.org/10.1016/j.apmr.2024.10.017
Vancouver
Esquenazi A, Zorowitz RD, Ashford S, Beneteau M, Maisonobe P, Hannes C, et al. Longitudinal Goal Attainment With Repeat Injections of AbobotulinumtoxinA in Adults With Lower Limb Spasticity: Results From a Prospective Observational Study. Archives of Physical Medicine and Rehabilitation. 2025. doi:10.1016/j.apmr.2024.10.017
BibTeX
@article{Esquenazi2025,
author = {Esquenazi, Alberto and Zorowitz, Richard D and Ashford, Stephen and Beneteau, Mathieu and Maisonobe, Pascal and Hannes, Christian and Jacinto, Jorge and AboLiSh Study Group, AboLiSh Study Group},
title = {Longitudinal Goal Attainment With Repeat Injections of AbobotulinumtoxinA in Adults With Lower Limb Spasticity: Results From a Prospective Observational Study},
journal = {Archives of Physical Medicine and Rehabilitation},
year = {2025},
doi = {10.1016/j.apmr.2024.10.017}
}
EUVIMED